LASE Innovation Inc.

LASE Innovation Inc. is a Boston-area techbio company commercializing LP™ Optical Cell Barcoding, a laser-particle technology that tags individual cells with narrowband light signatures tuned across more than 1,000 wavelengths. Spun out of the Wellman Center at Massachusetts General Hospital and MIT, the platform lets researchers run multiple passes of flow cytometry on the same sample, track the same cells over time, and connect single-cell data across flow, imaging and sequencing. The company is turning a long-standing limitation of flow cytometry - that you generally read a cell once and lose it - into a repeatable, trackable measurement.